Daniel Levangie is an experienced executive with senior operating experience in the field of medical devices and in vitro diagnostics. Mr. Levangie is currently the Chairman and Chief Executive Officer of Cerevasc, LLC and co-founder and Managing Partner of ATON Partners, LLC, a Boston based private investment and management consulting firm. Most recently, Mr. Levangie was Chief Executive Officer of Dune Medical Devices and co-founder and Managing Partner of Constitution Medical Investors, Inc. (CMI) a Boston-based private investment and product development firm acquired by Roche Diagnostics Corporation in July 2013. Prior to that Mr. Levangie was Chief Executive Officer of Keystone Dental, Inc., a Warburg Pincus portfolio company involved in dental reconstruction technologies and Chairman of the Board of ev3.
Beginning in 1992 Mr. Levangie held a variety of executive management positions with Cytyc Corporation until the acquisition of Cytyc Corporation by Hologic, Inc. in October of 2007. Those positions included Executive Vice President and Chief Operating Officer, Chief Executive Officer and President of Cytyc Health Corporation, Executive Vice President and Chief Commercial Officer and President, Cytyc Surgical Products Division.
Prior to joining Cytyc Corporation in 1992, Mr. Levangie held a number of sales, marketing and management positions with Abbott Laboratories, North Chicago, IL.
Mr. Levangie resides in Boston, MA with his wife Joan, and is a member of the Board of Directors of Exact Sciences, Inc. and Dune Medical Devices, LTD. He previously served as Lead Director of Insulet Corporation and Director of Liposcience, Inc. Mr. Levangie, a graduate of the College of Pharmacy of Northeastern University in Boston, is a member of the Advisory Board of the Barnett Institute of Northeastern University and is a trustee of Excel Charter School.
Patrick Sullivan is an experienced executive with an outstanding track record in managing early stage medical device and diagnostics ventures through all phases of growth. He is currently Managing Partner of ATON Partners, LLC and is President & Chief Executive Officer of Insulet Corporation (PODD). Prior to these roles Mr. Sullivan served as Chairman & CEO of Constitutional Medical Investors from 2008 until its sale to Roche Diagnostics Hematology in July 2013. From 1991 through 2007 Mr. Sullivan served in a variety of senior executive positions with Cytyc Corporation including Chairman, President and Chief Executive Officer until the acquisition of Cytyc Corporation by Hologic Corporation in October of 2007. Prior to joining Cytyc, Mr. Sullivan was employed in several senior marketing positions by Abbott Laboratories, a diversified healthcare company, and was a consultant with McKinsey & Company, an international management-consulting firm. Mr. Sullivan holds a Bachelor of Science degree, with Distinction, from the United States Naval Academy and a Master of Business Administration degree, with Distinction, from Harvard Business School. Mr. Sullivan is a Director of CereVasc, Perkin-Elmer Corporation and Theragenics Corporation.
Carl Heilman MD, is the Neurosurgeon-in-Chief at Tufts Medical Center. He is Chairman of the Department of Neurosurgery as well as a Professor at Tufts University School of Medicine. Internationally known for neurosurgical excellence, Dr. Heilman is the past president of the Boston Society of Neurology and Psychiatry, the New England Neurosurgical Society, the Society of University Neurosurgeons, and the North American Skull Base Society. He is currently one of the 14 Directors of the American Board of Neurological Surgeons.
Walter H. Colsman
Walter H. Colsman brings a wealth of medical device strategy and finance expertise to CereVasc as the company’s CFO.
Mr. Colsman was a senior analyst at Columbia-Threadneedle Investments, the sixth largest investment firm in the U.S. where he focused on the medical device sectors for 12 years. In this role he had frequent contact with senior management of the major public device companies. He also engaged with startup companies, often providing feedback on fundraising strategy and the IPO process. Prior to Columbia, Walter worked at Standard Pacific Capital and Palo Alto Investors, hedge funds in the San Francisco Bay Area.
Prior to his investing career, Mr. Colsman worked for several internet startups in the Bay Area including TimeDance, where he was a founder with leading VC funding, and Apexon, where he played a product development role.
Walter started his business career as a management consultant at Bain & Company and the Lucas Group. He advised clients on a variety of strategic projects including due diligence for several private equity clients that led to successful transactions. Walter also worked for Pepsi- Cola International in financial and strategic planning roles.
Walter is a graduate of Harvard Business School and Dartmouth College (engineering).
Mark Licari brings a wealth of manufacturing experience to CereVasc. Mark joins us from Insulet Corporation where he served as Vice President of Manufacturing Operations. While at Insulet he upgraded the company’s global supply chain and manufacturing effort during a period of rapid growth. Prior to Insulet Mark held similar roles at Novocure, Roche Diagnostics, and Cytyc Corporation. Mark also held engineering roles at Cytyc, Injectronics, HP, Millipore, and DEKA. Mark earned his B.S. in Plastics Engineering from University of Lowell.